无锡金年会有限公司，前身为无锡市第二制药厂，为江苏省高新技术企业和江苏省科技创新型企业, 始建于1943年，位于风景秀美的太湖之滨。公司注册资本32000万元人民币，占地面积100,000平方米。公司主要生产抗生素原料药、化学合成原料药以及口服固体制剂；发酵总量近500立方米，建有8个符合国内国际GMP要求的生产车间。
无锡金年会有限公司秉承“祈康厚生，福泽民众”的信念宗旨，致力于原料药和成品药研发和生产，为客户提供更好的产品与服务。公司质量管理体系完善，设备仪器先进，产品质量优良，配套设施完善。公司通过了由国内外药品监督管理机关组织中囯GMP（2010）及欧洲GMP认证，通过了清洁生产审核以及中经科环基于GB/T24001-2016 idt ISO14001：2015 标准的环境管理体系认证；GB/T45001-2020 idt ISO45001：2018 标准的职业健康安全管理体系认证。
公司拥有一大批高技术专业人士组成的人才队伍，从事着管理、科研、开发、生产、营销工作。
企业目前主要产品有硫酸奈替米星，硫酸西索米星，硫酸核糖霉素及螺旋霉素等抗生素药物，吗替麦考酚酯，他克莫司等器官移植抗排斥方面的药物，产品远销欧洲，美洲，非洲，及东南亚等几十个国家和地区。得天独厚的先天优势，造就了企业深厚的文化底蕴；雄厚的科学技术力量，为企业的长足发展创造了机遇。在以质量求生存，以创新谋发展的经营理念的指导下，无锡福祈积极开发治疗器官移植抗排斥药，新型抗肿瘤药以及保肝药等一系列的新产品，并逐渐稳步拓展成品药市场，为企业中长期的发展提供持久动力。
强大的研发实力，坚实的生产技术，先进的管理理念，创新的经营思路和不断自我提升的质量管理体系是无锡福祈的竞争优势，企业正努力把自身建设成为国内外知名的现代化制药企业。
WuxiFortune Pharmaceutical co., LTD is formerly known as Wuxi No. 2 Pharmaceutical Factory, is an new high-tech enterprise and technological innovation-based enterprise in Jiangsu Province. It was established in 1943 and located nearby the beautiful Taihu Lake. The registered capital is 320,000,000 RMB, and the total area is 100,000 m2. The main products are antibiotic APIs, chemical synthesis APIs and oral solid preparations. The total fermentation amount is about 500m3. There are eight workshops complied with the requirements of Current Chinese GMP (2010 version), which is equal to that of EU GMP, WHO GMP and ICH Q7A.
Wuxi Fortune pharmaceutical Co., LTD., adheres to the belief of "pray for the health, improve the living condition, bless the people", devotes to developing and manufacturing API and finished products, and provide better products and services. We have complete quality assurance system, advanced facility, providing good products, and perfect matching facilities. The company has passed the Chinese GMP (2010) Certification and European GMP Certification conducted by domestic and foreign regulatory administration authorities, cleaning production audit, the Environmental Management System Certification (GB/T24001-2016/ISO ISO14001:2015), and the Occupational Health and Safety Management System Certification (GB/T45001-2020/ISO 45001:2018) conducted by Beijing Zhongjing Quality Certification Co., Ltd.
At present, the main products are antibiotics drugs such as Netilmicin Sulfate, Sisomicin Sulfate, Ribostamycin Sulfate, and Spiramycin etc. and immunosuppressant like Mycophenolate Mofetiland Tacrolimus. Most of our products are exported to Europe, America, Africa, and Southeast Asia.
The advantagedsuperiority creates deep enterprise culture and the abundant science and technology strength create the development opportunities. Now Wuxi Fortune develops on the organ transplantation anti-rejection drugs, new antineoplastic and hepatoprotective. We also gradually expand the market of finished drug products to provide enduring power for the enterprise development. Strong research and development strength, firm production technology, advanced management ideas, innovative business ideas and continuous self-improvement quality management system are our competitive advantage. We work hard to make the enterprise become a famous modern pharmaceutical enterprise.
